Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 15 studies | 54% ± 18% | |
glutamatergic neuron | 12 studies | 65% ± 24% | |
GABAergic neuron | 9 studies | 54% ± 23% | |
oligodendrocyte | 8 studies | 27% ± 13% | |
astrocyte | 6 studies | 27% ± 14% | |
interneuron | 6 studies | 51% ± 14% | |
amacrine cell | 6 studies | 44% ± 19% | |
retina horizontal cell | 6 studies | 66% ± 19% | |
retinal ganglion cell | 5 studies | 30% ± 16% | |
neuron | 4 studies | 41% ± 12% | |
pancreatic A cell | 3 studies | 39% ± 8% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 49% ± 3% | |
endothelial cell | 3 studies | 46% ± 21% | |
GABAergic interneuron | 3 studies | 45% ± 17% | |
GABAergic amacrine cell | 3 studies | 44% ± 13% | |
glycinergic amacrine cell | 3 studies | 30% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4858.21 | 2631 / 2642 | 99% | 65.78 | 699 / 705 |
adrenal gland | 100% | 1815.60 | 257 / 258 | 65% | 5.90 | 149 / 230 |
ovary | 83% | 522.28 | 150 / 180 | 3% | 0.05 | 15 / 430 |
prostate | 66% | 331.91 | 162 / 245 | 20% | 0.49 | 100 / 502 |
liver | 34% | 134.39 | 77 / 226 | 33% | 1.25 | 133 / 406 |
breast | 41% | 196.29 | 189 / 459 | 23% | 1.26 | 258 / 1118 |
pancreas | 16% | 62.77 | 53 / 328 | 47% | 2.54 | 84 / 178 |
blood vessel | 62% | 289.21 | 827 / 1335 | 0% | 0 | 0 / 0 |
kidney | 25% | 112.97 | 22 / 89 | 24% | 0.73 | 216 / 901 |
uterus | 34% | 165.48 | 57 / 170 | 11% | 0.51 | 49 / 459 |
skin | 31% | 225.43 | 553 / 1809 | 4% | 0.13 | 18 / 472 |
intestine | 17% | 69.25 | 169 / 966 | 4% | 0.15 | 22 / 527 |
thymus | 4% | 25.32 | 27 / 653 | 17% | 0.86 | 103 / 605 |
heart | 19% | 80.04 | 162 / 861 | 0% | 0 | 0 / 0 |
adipose | 18% | 72.08 | 217 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.27 | 6 / 45 |
esophagus | 4% | 16.18 | 64 / 1445 | 6% | 0.15 | 11 / 183 |
stomach | 8% | 30.54 | 27 / 359 | 3% | 0.17 | 8 / 286 |
bladder | 5% | 12.43 | 1 / 21 | 4% | 0.22 | 22 / 504 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.09 | 2 / 29 |
lung | 1% | 3.68 | 7 / 578 | 5% | 0.10 | 52 / 1155 |
eye | 0% | 0 | 0 / 0 | 3% | 0.12 | 2 / 80 |
peripheral blood | 1% | 8.83 | 13 / 929 | 0% | 0 | 0 / 0 |
muscle | 0% | 1.25 | 3 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050804 | Biological process | modulation of chemical synaptic transmission |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0035235 | Biological process | ionotropic glutamate receptor signaling pathway |
GO_0034220 | Biological process | monoatomic ion transmembrane transport |
GO_0060291 | Biological process | long-term synaptic potentiation |
GO_0099505 | Biological process | regulation of presynaptic membrane potential |
GO_0051290 | Biological process | protein heterotetramerization |
GO_0060078 | Biological process | regulation of postsynaptic membrane potential |
GO_0007215 | Biological process | glutamate receptor signaling pathway |
GO_0035249 | Biological process | synaptic transmission, glutamatergic |
GO_0051289 | Biological process | protein homotetramerization |
GO_0098839 | Cellular component | postsynaptic density membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0043197 | Cellular component | dendritic spine |
GO_0030666 | Cellular component | endocytic vesicle membrane |
GO_0032281 | Cellular component | AMPA glutamate receptor complex |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0098688 | Cellular component | parallel fiber to Purkinje cell synapse |
GO_1904315 | Molecular function | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential |
GO_0001540 | Molecular function | amyloid-beta binding |
GO_0004970 | Molecular function | glutamate-gated receptor activity |
GO_0004971 | Molecular function | AMPA glutamate receptor activity |
GO_0099507 | Molecular function | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential |
GO_0022849 | Molecular function | glutamate-gated calcium ion channel activity |
Gene name | GRIA3 |
Protein name | Glutamate receptor 3 (GluR-3) (AMPA-selective glutamate receptor 3) (GluR-C) (GluR-K3) (Glutamate receptor ionotropic, AMPA 3) (GluA3) Glutamate receptor Glutamate ionotropic receptor AMPA type subunit 3 (Glutamate receptor, ionotrophic, AMPA 3) |
Synonyms | GLUR3 GLURC |
Description | FUNCTION: Receptor for glutamate that functions as a ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate. . FUNCTION: Receptor for glutamate that functions as a ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. . FUNCTION: Receptor for glutamate that functions as a ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. . FUNCTION: Receptor for glutamate that functions as a ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. . |
Accessions | ENST00000620581.4 ENST00000616590.4 P42263 Q9P0H2 Q17R51 ENST00000620443.2 [P42263-2] ENST00000611689.4 ENST00000622768.5 [P42263-1] Q5XKG2 A0A087WYJ6 |